Editorial: Contemporary Perspective on 5-HT2C Receptor Function and Its Pharmacological Targeting
Front. Pharmacol.. 2020-11-23; 11:
DOI: 10.3389/FPHAR.2020.606414
Read on PubMed
De Deurwaerdère P(1), Chagraoui A(2)(3), Cunningham KA(4).
Author information:
(1)Institut des Neurosciences Cognitives et Integratives d’Aquitaine, CNRS UMR
5287, Bordeaux, France.
(2)Neuronal and Neuroendocrine Differentiation and Communication Laboratory,
Institute for Research and Innovation in Biomedicine of Normandy (IRIB),
Normandie University, UNIROUEN, INSERM, U1239, Rouen, France.
(3)CHU Rouen, Rouen, France.
(4)Center for Addiction Research and Department of Pharmacology and Toxicology,
University of Texas Medical Branch, Galveston, TX, United States.
Conflict of interest statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.